4//SEC Filing
Dreyer Scott 4
Accession 0001062993-25-014766
CIK 0001267565other
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:57 PM ET
Size
11.5 KB
Accession
0001062993-25-014766
Insider Transaction Report
Form 4
Dreyer Scott
EVP & Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-08-18$21.34/sh+16,389$349,741→ 120,002 total - Sale
Common Stock
2025-08-18$38.21/sh−16,389$626,171→ 103,613 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-08-18−16,389→ 0 totalExercise: $21.34Exp: 2030-02-05→ Common Stock (16,389 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 28, 2024.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.465, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested and exercisable.
Issuer
COLLEGIUM PHARMACEUTICAL, INC
CIK 0001267565
Entity typeother
Related Parties
1- filerCIK 0001746251
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 4:57 PM ET
- Size
- 11.5 KB